Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

Market Cap	5.75B +48.9%
Revenue (ttm)	1.42B -3.8%
Net Income	127.19M +87.0%
EPS	0.63 +85.6%
Shares Out	196.11M
PE Ratio	46.52
Forward PE	n/a
Dividend	0.30 (1.02%)
Ex-Dividend Date	Jun 22, 2026

Volume	18,623,762
Open	27.46
Previous Close	29.06
Day's Range	27.46 - 29.80
52-Week Range	25.32 - 68.80
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,236
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002940

Financial Performance

In 2025, SHE:002940's revenue was 1.42 billion, a decrease of -7.35% compared to the previous year's 1.54 billion. Earnings were 125.44 million, an increase of 56.15%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error